Cargando…
Immune checkpoint blockade impairs immunosuppressive mechanisms of regulatory T cells in B-cell lymphoma
In malignant disease, CD4(+)Foxp3(+) regulatory T cells (Tregs) hamper antitumor immune responses and may provide a target for immunotherapy. Although immune checkpoint blockade (ICB) has become an established therapy for several cancer entities including lymphoma, its mechanisms have not been entir...
Autores principales: | Bauer, Vera, Ahmetlić, Fatima, Hömberg, Nadine, Geishauser, Albert, Röcken, Martin, Mocikat, Ralph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264214/ https://www.ncbi.nlm.nih.gov/pubmed/34229208 http://dx.doi.org/10.1016/j.tranon.2021.101170 |
Ejemplares similares
-
The role of dendritic cells for therapy of B-cell lymphoma with immune checkpoint inhibitors
por: Scheuerpflug, Anne, et al.
Publicado: (2020) -
Therapy of lymphoma by immune checkpoint inhibitors: the role of T cells, NK cells and cytokine-induced tumor senescence
por: Ahmetlic, Fatima, et al.
Publicado: (2021) -
Cancer immune control needs senescence induction by interferon-dependent cell cycle regulator pathways in tumours
por: Brenner, Ellen, et al.
Publicado: (2020) -
Specific targeting of whole lymphoma cells to dendritic cells ex vivo provides a potent antitumor vaccine
por: Adam, Christian, et al.
Publicado: (2007) -
Update on checkpoint blockade therapy for lymphoma
por: Kline, Justin, et al.
Publicado: (2015)